论文部分内容阅读
依达拉奉是一种强效自由基清除剂,能有效地避免脑缺血所致的损伤,因此能用于治疗有缺血倾向的脑栓塞,应用范围较肝素、阿加曲班等抗凝血药物和尼莫地平等抗血管药物更广泛,临床使用安全性高。另外,依达拉奉对心脏有保护作用,能有效抑制左心室肌细胞肌酸激酶活性的丧失,所以能用于心肌缺血再开通损害。本品已于2001年初首次在日本上市。根据文献报道,依达拉奉的制备方法主要有三种:1.苯
Edaravone is a potent free-radical scavenger that effectively avoids the damage caused by cerebral ischemia and is therefore of use in the treatment of ischemic-prone cerebral embolisms with a range of applications that are more resistant than heparin, argatroban Blood clotting drugs and nimotopoetic anti-angiogenic drugs more widely used in clinical safety. In addition, edaravone has a protective effect on the heart, can effectively inhibit the loss of creatine kinase activity in left ventricular myocytes, it can be used for myocardial ischemia reopen damage. This product was first listed in Japan in early 2001. According to the literature, edaravone has three main preparation methods: 1. Benzene